Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice.

[1]  Caroline H. Johnson,et al.  Identification of dose-dependent DNA damage and repair responses from subchronic exposure to 1,4-dioxane in mice using a systems analysis approach. , 2021, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  D. Shou,et al.  Metabolomics study of the hepatoprotective effect of Phellinus igniarius in chronic ethanol-induced liver injury mice using UPLC-Q/TOF-MS combined with ingenuity pathway analysis. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  Zhiwei Peng,et al.  Differential Metabolic Pathways and Metabolites in a C57BL/6J Mouse Model of Alcoholic Liver Disease , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[4]  C. McClain,et al.  Mechanisms, Biomarkers and Targets for Therapy in Alcohol-associated Liver Injury: From Genetics to Nutrition: Summary of the ISBRA 2018 Symposium. , 2020, Alcohol.

[5]  H. Gika,et al.  Study of Fecal and Urinary Metabolite Perturbations Induced by Chronic Ethanol Treatment in Mice by UHPLC-MS/MS Targeted Profiling , 2019, Metabolites.

[6]  Shunlin Qu,et al.  Farnesoid X receptor: An important factor in blood glucose regulation. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[7]  W. Pandak,et al.  The acidic pathway of bile acid synthesis: Not just an alternative pathway , 2019, Liver research.

[8]  Ronan M. T. Fleming,et al.  Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease , 2019, Microbiome.

[9]  P. Dawson,et al.  Animal models to study bile acid metabolism. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[10]  Xin Xiong,et al.  Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics , 2019, Nature Communications.

[11]  Nitzan C Roth,et al.  Histopathology of Alcohol-Related Liver Diseases. , 2019, Clinics in liver disease.

[12]  J. Rabinowitz,et al.  Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice , 2018, The Journal of clinical investigation.

[13]  Adrianne L. Stefanski,et al.  Maternal obesity during lactation may protect offspring from high fat diet-induced metabolic dysfunction , 2018, Nutrition & Diabetes.

[14]  Daniel M. Rotroff,et al.  Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome , 2018, Alzheimer's & Dementia.

[15]  A. Kalsbeek,et al.  Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System , 2017, Front. Neurosci..

[16]  Shuzhao Li,et al.  One Step Forward for Reducing False Positive and False Negative Compound Identifications from Mass Spectrometry Metabolomics Data: New Algorithms for Constructing Extracted Ion Chromatograms and Detecting Chromatographic Peaks. , 2017, Analytical chemistry.

[17]  Ralf J. M. Weber,et al.  A complete workflow for high-resolution spectral-stitching nanoelectrospray direct-infusion mass-spectrometry-based metabolomics and lipidomics , 2017, Nature Protocols.

[18]  Hanns-Ulrich Marschall,et al.  Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. , 2016, Cell metabolism.

[19]  Surendra Singh,et al.  Chronic Glutathione Depletion Confers Protection against Alcohol-induced Steatosis: Implication for Redox Activation of AMP-activated Protein Kinase Pathway , 2016, Scientific Reports.

[20]  P. Haber,et al.  Alcoholic Liver Disease in Asia, Europe, and North America. , 2016, Gastroenterology.

[21]  R. Bataller,et al.  Pathogenesis and Management of Alcoholic Liver Disease , 2016, Digestive Diseases.

[22]  P. Hylemon,et al.  Consequences of bile salt biotransformations by intestinal bacteria , 2016, Gut microbes.

[23]  J. Chiang.  Negative feedback regulation of bile acid metabolism: Impact on liver metabolism and diseases , 2015, Hepatology.

[24]  N. Sheron,et al.  Alcoholic liver disease - the extent of the problem and what you can do about it. , 2015, Clinical medicine.

[25]  W. Ding,et al.  Role of farnesoid X receptor and bile acids in alcoholic liver disease , 2015, Acta pharmaceutica Sinica. B.

[26]  Li Yang,et al.  Bile acid nuclear receptor FXR and digestive system diseases , 2015, Acta pharmaceutica Sinica. B.

[27]  J. Chiang,et al.  Bile Acid Signaling in Metabolic Disease and Drug Therapy , 2014, Pharmacological Reviews.

[28]  T. Luedde,et al.  Cell death and cell death responses in liver disease: mechanisms and clinical relevance. , 2014, Gastroenterology.

[29]  Yongjae Lee,et al.  Chronic liver inflammation: clinical implications beyond alcoholic liver disease. , 2014, World journal of gastroenterology.

[30]  M. Indira,et al.  Ascorbic acid suppresses endotoxemia and NF-κB signaling cascade in alcoholic liver fibrosis in guinea pigs: a mechanistic approach. , 2014, Toxicology and applied pharmacology.

[31]  Jianxin Gu,et al.  Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease. , 2014, Biochemical and biophysical research communications.

[32]  J. Muntané,et al.  Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition. , 2013, Biochemical pharmacology.

[33]  J. Seo,et al.  Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease , 2013, Pediatric gastroenterology, hepatology & nutrition.

[34]  Natalie I. Tasman,et al.  A Cross-platform Toolkit for Mass Spectrometry and Proteomics , 2012, Nature Biotechnology.

[35]  H. Jaeschke,et al.  Effect of bile duct ligation on bile acid composition in mouse serum and liver , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[36]  James R. Roede,et al.  Chronic ethanol consumption in mice alters hepatocyte lipid droplet properties. , 2011, Alcoholism, clinical and experimental research.

[37]  Brian C. Jackson,et al.  Aldehyde Dehydrogenase 1B1: Molecular Cloning and Characterization of a Novel Mitochondrial Acetaldehyde-Metabolizing Enzyme , 2010, Drug Metabolism and Disposition.

[38]  J. Chiang,et al.  Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.

[39]  David S. Wishart,et al.  MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..

[40]  I. Rusyn,et al.  Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. , 2008, Toxicology and applied pharmacology.

[41]  Johan Auwerx,et al.  Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.

[42]  D. Caruso,et al.  Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[43]  N. Kaplowitz,et al.  Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. , 2006, Journal of hepatology.

[44]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[45]  J. Lefkowitch.  Morphology of alcoholic liver disease. , 2005, Clinics in liver disease.

[46]  D. Crabb,et al.  The role of AMP-activated protein kinase in the action of ethanol in the liver. , 2004, Gastroenterology.

[47]  D. Crabb,et al.  Peroxisome Proliferator-activated Receptor α (PPARα) Agonist Treatment Reverses PPARα Dysfunction and Abnormalities in Hepatic Lipid Metabolism in Ethanol-fed Mice* , 2003, Journal of Biological Chemistry.

[48]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[49]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[50]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[51]  Surendra Singh,et al.  Engineered Animal Models Designed for Investigating Ethanol Metabolism, Toxicity and Cancer. , 2018, Advances in experimental medicine and biology.

[52]  P. Mathurin,et al.  [Alcoholic hepatitis]. , 2018, La Revue du praticien.

[53]  K. Kharbanda,et al.  Alcoholic Liver Disease: Pathogenesis and Current Management , 2017, Alcohol research : current reviews.

[54]  U. Apte,et al.  Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer. , 2015, Advances in pharmacology.

[55]  Ian D Wilson,et al.  Global metabolic profiling for the study of alcohol-related disorders. , 2014, Bioanalysis.